Updates and Statements

09.17.2019

TrialSpark and Pfizer collaborating to improve speed and access to clinical trials

09.17.2019

Terry Bradshaw and Pfizer Educate Boomers About the Risks of Pneumococcal Pneumonia and the Importance of Vaccination

06.04.2018

Hospira Issues A Voluntary Nationwide Recall For Two Lots of Naloxone Hydrochloride Injection, USP, in the Carpuject™ Syringe System Due To The Potential Presence of Particulate Matter.

05.24.2018

Pfizer Reaches $23.85 Million Settlement Agreement To Resolve Allegations Related To Patient Assistance Charities

05.09.2018

Important Notice Regarding EpiPen auto-injector supply

04.30.2018

Dawn Rogers Appointed Executive Vice President of Pfizer Worldwide Human Resources

03.05.2018

Hospira Issues A Voluntary Nationwide Recall For Hydromorphone HCL Injection, USP CII Due To The Potential For Empty Or Cracked Glass Vials

02.23.2018

Hospira Issues A Voluntary Nationwide Recall For Labetalol Hydrochloride Injection, USP, Due To The Potential Of Cracked Glass At The Rim Surface Of The Vials